Children with KCN have greater risk of progression than adults; study findings suggest CXL may slow that progression or prevent it altogether.
Gerald Zaidman, MD
Advertisement
Articles by Gerald Zaidman, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
Brensocatib Patient Selection Evolves 1 Year After FDA Approval
2
CKM Syndrome, Artery Damage Prevalence Higher in Young Adults than Previously Believed
3
ABTECT Maintenance Data Show Durable Remission in UC, With Remo Panaccione, MD
4
Why Mentorship Matters Most for Dermatology Trainees
5